TSPAN16 is a tetraspanin family member expressed on the plasma membrane with roles in cellular organization and disease pathogenesis. Tetraspanins are characterized by four transmembrane domains and regulate cell adhesion, migration, proliferation, and differentiation 1. TSPAN16 specifically participates in actin cytoskeleton regulation, functioning alongside RAB11FIP3 in this process 2. In disease contexts, TSPAN16 emerges as a significant hub gene in fibromyalgia pathophysiology. As part of an 11-gene signature identifying immune-related molecular subtypes, TSPAN16 shows negative correlation with CD4/CD8 T cell infiltration while positively correlating with macrophages, mast cells, monocytes, and neutrophils, as well as inflammatory response and angiogenesis pathways 3. Additionally, TSPAN16 is underexpressed in p185BCR-ABL-positive acute lymphoblastic leukemia relative to p210BCR-ABL-positive subtypes 4, suggesting differential involvement in BCR-ABL-mediated leukemogenesis. Regarding cardiac relevance, TSPAN16 was identified as a top candidate gene associated with prevalent heart failure with reduced ejection fraction in an integrative transomics analysis of the Framingham Heart Study 2. These findings suggest TSPAN16 participates in both immune dysregulation and cardiac remodeling, though mechanistic details require further investigation.